Colfax Co. (NYSE:CFX) Shares Bought by Van Den Berg Management I Inc.

Van Den Berg Management I Inc. lifted its position in Colfax Co. (NYSE:CFX) by 7.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,163,515 shares of the industrial products company’s stock after buying an additional 76,484 shares during the quarter. Colfax makes up 5.2% of Van Den Berg Management I Inc.’s investment portfolio, making the stock its 3rd largest holding. Van Den Berg Management I Inc. owned approximately 0.94% of Colfax worth $46,098,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of CFX. The Manufacturers Life Insurance Company raised its holdings in shares of Colfax by 7.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,688 shares of the industrial products company’s stock valued at $145,000 after buying an additional 251 shares during the period. Nationwide Fund Advisors raised its holdings in shares of Colfax by 752.0% in the 3rd quarter. Nationwide Fund Advisors now owns 164,055 shares of the industrial products company’s stock valued at $6,831,000 after buying an additional 144,800 shares during the period. Prudential Financial Inc. raised its holdings in shares of Colfax by 19.6% in the 3rd quarter. Prudential Financial Inc. now owns 34,755 shares of the industrial products company’s stock valued at $1,447,000 after buying an additional 5,700 shares during the period. Sei Investments Co. raised its holdings in shares of Colfax by 1,025.9% in the 3rd quarter. Sei Investments Co. now owns 11,327 shares of the industrial products company’s stock valued at $472,000 after buying an additional 10,321 shares during the period. Finally, New York State Common Retirement Fund raised its holdings in shares of Colfax by 4.0% in the 3rd quarter. New York State Common Retirement Fund now owns 198,600 shares of the industrial products company’s stock valued at $8,270,000 after buying an additional 7,600 shares during the period. Hedge funds and other institutional investors own 77.54% of the company’s stock.

In other news, EVP Daniel A. Pryor sold 1,682 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $33.46, for a total value of $56,279.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP A. Lynne Puckett sold 7,270 shares of the business’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $42.01, for a total value of $305,412.70. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 11,445 shares of company stock valued at $444,983. Insiders own 10.60% of the company’s stock.

Shares of NYSE:CFX traded down $1.10 on Monday, hitting $30.80. 760,518 shares of the company’s stock were exchanged, compared to its average volume of 833,191. The stock has a market cap of $3,934.17, a P/E ratio of 17.70, a P/E/G ratio of 1.12 and a beta of 1.26. Colfax Co. has a 1-year low of $30.50 and a 1-year high of $43.29. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.49 and a current ratio of 1.89.

Colfax (NYSE:CFX) last released its quarterly earnings data on Tuesday, February 6th. The industrial products company reported $0.45 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.44 by $0.01. The business had revenue of $874.00 million during the quarter, compared to analysts’ expectations of $894.02 million. Colfax had a return on equity of 5.95% and a net margin of 4.28%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.46 EPS. equities research analysts predict that Colfax Co. will post 2.11 EPS for the current year.

Several research analysts recently commented on CFX shares. Argus reissued a “buy” rating and set a $33.36 target price (down from $40.00) on shares of Colfax in a research note on Thursday, February 22nd. Robert W. Baird lowered their target price on Colfax from $47.00 to $42.00 and set an “outperform” rating for the company in a research note on Wednesday, February 7th. Stifel Nicolaus reissued a “buy” rating and set a $48.00 target price (up from $44.00) on shares of Colfax in a research note on Tuesday, January 16th. Gabelli raised Colfax from a “hold” rating to a “buy” rating in a research note on Wednesday, February 7th. They noted that the move was a valuation call. Finally, KeyCorp lowered their target price on Colfax from $46.00 to $44.00 and set an “overweight” rating for the company in a research note on Wednesday, February 7th. Three analysts have rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $42.74.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by Enterprise Leader and is owned by of Enterprise Leader. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://theenterpriseleader.com/2018/04/02/colfax-corp-nysecfx-holdings-lifted-by-van-den-berg-management-i-inc.html.

Colfax Profile

Colfax Corporation operates as a diversified industrial technology company worldwide. The company operates through Air and Gas Handling, and Fabrication Technology segments. The Air and Gas Handling segment designs, manufactures, and supplies heavy-duty centrifugal and axial fans, rotary heat exchangers, and gas compressors, as well as related products, systems, and services.

Institutional Ownership by Quarter for Colfax (NYSE:CFX)

Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply